Based in Galway, Ireland and Boston, MA, Atlantic Therapeutics develops consumer medical devices, related software, apps and connected health technologies to treat all types of incontinence, including INNOVO®, an FDA-Approved, CE-marked treatment for women suffering from Stress Urinary Incontinence. We believe that every woman deserves the freedom and confidence of good pelvic health and access to safe and effective treatments to achieve that outcome. Atlantic Therapeutics has attracted both international VC investment and enterprise grant funding and is now poised to begin this exciting new phase of growth and establish itself as the leading Femtech solution provider to treat SUI.